Amarin gains on AMR101 patent action

Amarin Corp. plc (NASDAQ:AMRN) was up $1.13 to $14.29 on Wednesday after the U.S. Patent and Trademark Office posted a number of documents on Tuesday for Amarin's Patent Application No. 12/702,889 and two continuation applications covering lead candidate AMR101. Jefferies analyst Thomas Wei said the actions were "positive" and are a sign the PTO could be closer to issuing patent protection through 2030 for AMR101 in the U.S. (see BioCentury Extra, Nov. 4, 2011). ...